Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV episode artwork

EPISODE · Dec 19, 2024 · 12 MIN

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

from Hippo Education Presents: The Monthly Rounds

Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts

NOW PLAYING

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

0:00 12:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Hippo Education Presents: The Monthly Rounds?

This episode is 12 minutes long.

When was this Hippo Education Presents: The Monthly Rounds episode published?

This episode was published on December 19, 2024.

What is this episode about?

Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts

Can I download this Hippo Education Presents: The Monthly Rounds episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!